Literature DB >> 26921688

Not routine screening, but vigilance for chronic liver disease in patients with type 2 diabetes.

Vincent Wai-Sun Wong1, Naga Chalasani2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26921688     DOI： 10.1016/j.jhep.2016.02.032

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  10 in total

1.  Screening for Nonalcoholic Fatty Liver Disease in the Primary Care Clinic.

Authors:  Vijay Pandyarajan; Robert G Gish; Naim Alkhouri; Mazen Noureddin
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-07

2.  Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease.

Authors:  Myriam Alexander; A Katrina Loomis; Jolyon Fairburn-Beech; Johan van der Lei; Talita Duarte-Salles; Daniel Prieto-Alhambra; David Ansell; Alessandro Pasqua; Francesco Lapi; Peter Rijnbeek; Mees Mosseveld; Paul Avillach; Peter Egger; Stuart Kendrick; Dawn M Waterworth; Naveed Sattar; William Alazawi
Journal:  BMC Med       Date:  2018-08-13       Impact factor: 8.775

Review 3.  Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association.

Authors:  Byung Wan Lee; Yong Ho Lee; Cheol Young Park; Eun Jung Rhee; Won Young Lee; Nan Hee Kim; Kyung Mook Choi; Keun Gyu Park; Yeon Kyung Choi; Bong Soo Cha; Dae Ho Lee
Journal:  Diabetes Metab J       Date:  2020-05-11       Impact factor: 5.376

Review 4.  Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease.

Authors:  Dae Ho Lee
Journal:  Endocrinol Metab (Seoul)       Date:  2020-06-24

5.  Recommendations for the management of non-alcoholic fatty liver disease (NAFLD).

Authors:  Krzysztof Tomasiewicz; Robert Flisiak; Waldemar Halota; Jerzy Jaroszewicz; Dariusz Lebensztejn; Wojciech Lisik; Piotr Małkowski; Małgorzata Pawłowska; Anna Piekarska; Krzysztof Simon; Olga Tronina
Journal:  Clin Exp Hepatol       Date:  2018-09-10

6.  Position statement on the diagnosis and management of non-alcoholic fatty liver disease.

Authors:  Khalid A Alswat; Hind I Fallatah; Bandar Al-Judaibi; Hussien A Elsiesy; Waleed K Al-Hamoudi; Adel N Qutub; Naif Alturaify; Abdullah Al-Osaimi
Journal:  Saudi Med J       Date:  2019-06       Impact factor: 1.484

Review 7.  Natural History of Nonalcoholic Fatty Liver Disease: Implications for Clinical Practice and an Individualized Approach.

Authors:  Ivica Grgurevic; Kristian Podrug; Ivana Mikolasevic; Michal Kukla; Anita Madir; Emmanuel A Tsochatzis
Journal:  Can J Gastroenterol Hepatol       Date:  2020-01-21

8.  Liver and Nonliver-Related Outcomes at 2 Years Are Not Influenced by the Results of the FIB-4 Test and Liver Elastography in a Real-Life Cohort of Patients with Type 2 Diabetes.

Authors:  Ivica Grgurevic; Nermin Salkic; Sanda Mustapic; Tomislav Bokun; Kristian Podrug; Srecko Marusic; Dario Rahelic; Tomas Matic; Viktoria Skurla; Ivana Mikolasevic
Journal:  Can J Gastroenterol Hepatol       Date:  2021-03-08

Review 9.  NAFLD and Extra-Hepatic Comorbidities: Current Evidence on a Multi-Organ Metabolic Syndrome.

Authors:  Valerio Rosato; Mario Masarone; Marcello Dallio; Alessandro Federico; Andrea Aglitti; Marcello Persico
Journal:  Int J Environ Res Public Health       Date:  2019-09-14       Impact factor: 3.390

Review 10.  The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD).

Authors:  Daniela Maria Tanase; Evelina Maria Gosav; Claudia Florida Costea; Manuela Ciocoiu; Cristina Mihaela Lacatusu; Minela Aida Maranduca; Anca Ouatu; Mariana Floria
Journal:  J Diabetes Res       Date:  2020-07-31       Impact factor: 4.011
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.